Plus500 does not provide CFD services to residents of the United States. Visit our U.S. website at us.plus500.com.

28 Nov Weekly Recap: Crypto & Obesity Drug Stocks Surge, Inflation Data & More

As we approach the end of November 2024, financial markets have experienced significant developments, from Bitcoin's remarkable surge to pivotal economic indicators influencing commodities and stocks. 

Let’s take a closer look at this week’s highlights:

Business meeting analysing digital charts and graphs

Bitcoin Retreats from $100,000 

Bitcoin (BTCUSD) recently neared the $100,000 threshold, marking a historic moment for the cryptocurrency market. However, it experienced a pullback to approximately $95,776. Some market experts suggest that Bitcoin was "extremely overbought" post-election, leading to this stall. Investors are closely monitoring its trajectory. Read more about Bitcoin's market performance.

Stocks Benefiting from Bitcoin's Surge

Companies with significant Bitcoin exposure, such as MicroStrategy, Coinbase, and BlackRock, have seen notable stock performance. MicroStrategy's shares have soared by 540% this year, reflecting trader optimism towards digital assets, especially under the incoming administration. However, the company's heavy reliance on Bitcoin introduces volatility risks. Read more on stocks riding Bitcoin's surge.

Gold and Oil Prices Decline Amid Market Developments

Gold prices declined by around 2%, ending a five-day winning streak. This movement was influenced by potential de-escalation in the Middle East and announcements regarding the next U.S. Treasury Secretary. Similarly, oil prices fell due to rumours of a possible ceasefire between Israel and Hezbollah, with Brent and WTI down by 2.9% and 3.2%, respectively. Read more about the decline in gold and oil prices.

Obesity Drug Stocks and Small Caps on the Rise

Shares of pharmaceutical companies like Eli Lilly and Novo Nordisk rose following proposals to expand access to anti-obesity medications. Additionally, the Russell 2000 small-cap index reached a new all-time high, driven by optimism for U.S. domestic companies under the anticipated new administration. Read more on obesity drug stocks and Russell 2000's rise.

Global Economic Updates: Inflation and Interest Rates

The U.S. Personal Consumption Expenditure (PCE) report indicated that inflation remains above the Federal Reserve's target, suggesting that interest rate cuts may not occur soon. Meanwhile, the Reserve Bank of New Zealand cut rates by 50 basis points as inflation approached its target range. Read more about global economic updates.

In summary, this week has showcased significant financial movements, with Bitcoin nearing unprecedented highs, commodities reacting to geopolitical developments, and stocks responding to policy proposals and economic data.

TL;DR FAQs

Did Bitcoin reach $100,000 this week?

No. Bitcoin approached the $100,000 mark last weekend but pulled back to around $95,776 earlier this week. Analysts attribute this to overbought conditions post-election.

How did gold and oil prices perform?

Both gold and oil prices declined, influenced by potential Middle East de-escalation and announcements regarding U.S. economic policy.

What were the significant stock market movements?

Stocks of companies like MicroStrategy, Coinbase, and BlackRock benefited from Bitcoin's surge. Pharmaceutical stocks rose due to proposed expansions in anti-obesity medication access, and the Russell 2000 index reached a new high.

Most recent articles

Related News & Market Insights


Get more from Plus500

Expand your knowledge

Learn insights through informative videos, webinars, articles, and guides with our comprehensive Trading Academy.

Explore our +Insights

Discover what’s trending in and outside of Plus500.


This information is written by Plus500 Ltd. The information is provided for general purposes only, and does not take into account any personal circumstances or objectives. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. No representation or warranty is given as to the accuracy or completeness of this information. It does not constitute financial, investment or other advice on which you can rely. Any references to past performance, historical returns, future projections, and statistical forecasts are no guarantee of future returns or future performance. Plus500 will not be held responsible for any use that may be made of this information and for any consequences that may result from such use. Hence, any person acting based on this information does so at their own discretion. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research.

Need Help?
24/7 Support